North European Life Science Summit in Schwerin
Co-operation partnering for pharmaceutical development at international level
Under the auspices of the North European biotechnology-initiative ScanBalt the Life Science networks Medicon Valley Academy Kopenhagen/Lund, NORGENTA Hamburg/Schleswig-Holstein and BioCon Valley Mecklenburg-Vorpommern invite to the workshop "Innovative Medicines - Collaboration in Northern Europe",Thursday, 22nd February 2007, 04:00 p.m. at the "Ritterstuben" (Ritterstraße 3, Ministry of Finance) in Schwerin.
It is objective of the event, to inform about the central European "Innovative Medicines Initiative (IMI)" for competitive pharmaceutical development as well as the special devoted funding in the frame of EU-FP7 and to mobilize partners for a co-operation. The event is devoted to interested scientists from academia and industry.
The overall objective of IMI is to remove bottlenecks hampering the efficiency of the development of new medicines, and where research is the key, thereby enabling the European biopharmeceutical industry to become world leaders. At the same time, by pooling resources from all stakeholders (industry, academia, SMEs, regulatory authorities, healthcare providers, patient organisations), this initiative is expected to provide faster access to better medicines for European citizens. The proposed EC contribution to the IMI JTI will be 1 billion € for the period of FP7 (2007-2013).
Speakers are Prof. Dr. Arnd Hoeveler, EC Research Directorate General, Head of Biotechnology Unit, Brussels, Dr. Erich Greiner, Evotec AG Hamburg, Prof. Dr.-Ing. Norbert Stoll and Prof. Dr. Arndt Rolfs, CELISCA Centre for Life Science Automation, University Rostock, as well as Stina Gestrelius, Deputy Managing Director Medicon Valley Academy, Copenhagen/Lund.
Following, the speakers as well as the teams of BioCon Valley, Medicon Valley and NORGENTA will be at disposal for individual discussions during the refreshment.
The representatives of media are cordially invited to take part at the workshop.
BioCon Valley® GmbH
Dr. Heinrich Cuypers
T +49 (0) 3834-515 108
F +49 (0) 3834-515 102
Peter Frank | idw
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Mapping the interaction of a single atom with a single photon may inform design of quantum devices
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...